Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
It is important to emphasise that GLP-1 receptor agonists are not currently licensed specifically for treating inflammatory conditions in the UK
Tirzepatide is FDA-approved for type 2 diabetes management and for chronic weight management, also under established brand names
Dietary and lifestyle modifications: Patients benefit from specific guidance regarding eating patterns and food choices: Smaller, more frequent meals Consuming 5-6 small meals rather than 3 large meals reduces gastric distension Slower eating pace Taking 20-30 minutes per meal and chewing thoroughly Avoiding high-fat foods Fatty meals delay gastric emptying further and may exacerbate symptoms Limiting very high-fiber foods During symptomatic periods, as these can worsen bloating Limiting carbonated beverages Reducing bloating and distension Adequate hydration Maintaining fluid intake between meals rather than with meals Remaining upright after eating Avoiding recumbent positions for 2-3 hours post-meal Symptomatic management: When lifestyle modifications prove insufficient, pharmacological interventions may provide relief
James, S
Don't miss out on our latest breakthrough
US$ 22.23
US$ 28.24
US$ 22.93
US$ 20.63
US$ 28.36
US$ 20.74
US$ 25.18
US$ 25.61
US$ 22.76
